Oncotype DX® genetic testing for breast cancer to be an IHCP covered service

Effective April 1, 2014, the Indiana Health Coverage Programs (IHCP) will add Oncotype DX genetic testing of breast cancer tumors as a covered service. This service may be billed with procedure code S3854 – Gene expression profiling panel for use in the management of breast cancer treatment. The IHCP covers Oncotype DX when it is considered medically necessary for managing the treatment of breast cancer. The 21-gene RT-PCR assay should only be ordered after surgery and subsequent pathological examination of the tumor have been completed. The IHCP requires a prior authorization (PA).